The COVID-19 pandemic has presented unprecedented challenges around the world, including to national public health systems and the international biopharmaceutical industry.
Establishing the suitability of packaging systems for pharmaceutical products is critical. With many new materials and applications entering the marketplace, testing procedures for these systems need to be revised regularly to make sure quality attributes are considered. To that end, USP has started an effort to modernize its packaging standards. Learn more.
Plastic packaging systems play an important role in protecting the drugs we use. However, a drug’s packaging must be compatible with the product and not compromise its stability, efficacy or safety. USP’s Desmond Hunt, Ph.D., provides insight into plastic packaging systems for drugs and how USP standards can support quality in this field.
One of the most transformative trends in pharma in recent years has been the explosive growth in biologic drug development. While these medicines have opened doors for treating many different cancers, autoimmune disorders, and chronic diseases such as diabetes, biologics have presented some new challenges related to packaging systems.
